Abstract:The cell cycle is implicated in diseases that are the leading cause of mortality and morbidity in the developed world. Until recently, the search for drug targets has focused on relatively small parts of the regulatory network under the assumption that key events can be controlled by targeting single pathways. This is valid provided the impact of couplings to the wider scale context of the network can be ignored. The resulting depth of study has revealed many new insights; however, these have been won at the expense of breadth and a proper understanding of the consequences of links between the different parts of the network. Since it is now becoming clear that these early assumptions may not hold and successful treatments are likely to employ drugs that simultaneously target a number of different sites in the regulatory network, it is timely to redress this imbalance. However, the substantial increase in complexity presents new challenges and necessitates parallel theoretical and experimental approaches. We review the current status of theoretical models for the cell cycle in light of these new challenges. Many of the existing approaches are not sufficiently comprehensive to simultaneously incorporate the required extent of couplings. Where more appropriate levels of complexity are incorporated, the models are difficult to link directly to currently available data. Further progress requires a better integration of experiment and theory. New kinds of data are required that are quantitative, have a higher temporal resolution and that allow simultaneous quantitative comparison of the concentration of larger numbers of different proteins. More comprehensive models are required and must accommodate not only substantial uncertainties in the structure and kinetic parameters of the networks, but also high levels of ignorance. The most recent results relating network complexity to robustness of the dynamics provide clues that suggest progress is possible.

Biological control networks suggest the use of biomimetic sets for combinatorial therapies

Identification of Optimal Strategies for State Transition of Complex Biological Networks.

[State Regulation for Complex Biological Networks Based on Dynamic Optimization Algorithms].

Optimal Control Nodes in Disease-Perturbed Networks As Targets for Combination Therapy.

Identification of Regulatory Variables for State Transition of Biological Networks.

Biomolecular Network Controllability with Drug Binding Information

Systems approaches and algorithms for discovery of combinatorial therapies

Target Control in Logical Models Using the Domain of Influence of Nodes

Identification of control targets in Boolean molecular network models via computational algebra

Network Pharmacology: Exploring the Resources and Methodologies.

Reducing State Conflicts between Network Motifs Synergistically Enhances Cancer Drug Effects and Overcomes Adaptive Resistance

Dynamical Methods for Target Control of Biological Networks

Global stabilizing control of large-scale biomolecular regulatory networks

Structural characteristics in network control of molecular multiplex networks

Exploring Drug Combinations in Genetic Interaction Network

Modular control of Boolean network models

Bifurcation-based approach reveals synergism and optimal combinatorial perturbation

The role of modelling in identifying drug targets for diseases of the cell cycle

MODEL-BASED IDENTIFICATION AND ADAPTIVE CONTROL OF THE CORE MODULE IN A TYPICAL CELL CYCLE PATHWAY VIA NETWORK AND SYSTEM CONTROL THEORIES

The basis of easy controllability in Boolean networks

Synergistic and Antagonistic Drug Combinations Depend on Network Topology.